human [allogeneic] chondrocyte therapy(Cellseed)

N/A

Report date: 2024/08/13 20:00:09

Base Information

Drug Namehuman [allogeneic] chondrocyte therapy(Cellseed)
Drug Alias NameCLS2901CCLS-2901C
ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Somatic cell > Cartilage cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsOsteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesCellseed Inc
China Registration ClassN/A

Develop Information

Active CompaniesCellseed Inc
Inactive CompaniesN/A
Active IndicationsOsteoarthritis, Knee
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A